AU6271098A - Hiv integrase inhibitors - Google Patents

Hiv integrase inhibitors

Info

Publication number
AU6271098A
AU6271098A AU62710/98A AU6271098A AU6271098A AU 6271098 A AU6271098 A AU 6271098A AU 62710/98 A AU62710/98 A AU 62710/98A AU 6271098 A AU6271098 A AU 6271098A AU 6271098 A AU6271098 A AU 6271098A
Authority
AU
Australia
Prior art keywords
hiv integrase
integrase inhibitors
inhibitors
hiv
integrase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62710/98A
Inventor
Gerald F. Bills
Russell B Lingham
Fernando Pelaez
Ali Shafiee
Keith C. Silverman
Sheo Bux Singh
Ana M. Teran
Deborah L. Zink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9707492.6A external-priority patent/GB9707492D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU6271098A publication Critical patent/AU6271098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62710/98A 1997-02-06 1998-02-03 Hiv integrase inhibitors Abandoned AU6271098A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3690297P 1997-02-06 1997-02-06
US60036902 1997-02-06
GB9707492 1997-04-14
GBGB9707492.6A GB9707492D0 (en) 1997-04-14 1997-04-14 HIV integrase inhibitors
PCT/US1998/002292 WO1998034932A1 (en) 1997-02-06 1998-02-03 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
AU6271098A true AU6271098A (en) 1998-08-26

Family

ID=26311374

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62710/98A Abandoned AU6271098A (en) 1997-02-06 1998-02-03 Hiv integrase inhibitors

Country Status (4)

Country Link
EP (1) EP1023281A4 (en)
AU (1) AU6271098A (en)
CA (1) CA2280518A1 (en)
WO (1) WO1998034932A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011246A (en) * 1999-06-02 2002-03-05 Shionogi & Co Processes for the preparation of new substituted propenone derivatives
GB0200957D0 (en) * 2002-01-17 2002-03-06 Secr Defence Novel polymer and uses thereof
US20070041971A1 (en) * 2003-07-07 2007-02-22 Wagner David H Methods for predicting development of auto-immune diseases and treatment of same
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
CN113717145B (en) * 2021-09-18 2023-05-26 中国热带农业科学院热带作物品种资源研究所 Dinaphtho r-pyrone compound and application thereof in resisting plant anthrax

Also Published As

Publication number Publication date
EP1023281A1 (en) 2000-08-02
WO1998034932A1 (en) 1998-08-13
EP1023281A4 (en) 2000-08-02
CA2280518A1 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
AU3118200A (en) Hiv integrase inhibitors
AU6873398A (en) Table construction
AU6616400A (en) Hiv integrase inhibitors
AU5387898A (en) Pharmaceutical agents
EP1086091A4 (en) Hiv integrase inhibitors
AU1285300A (en) Hiv vaccine
AU8009900A (en) Hiv integrase inhibitors
AU1408300A (en) Hiv infection inhibitors
AU8591898A (en) Pharmaceutical compounds
AU3366899A (en) Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
AUPO865797A0 (en) Range finding
AUPM982594A0 (en) HIV protease inhibitors
GB9621974D0 (en) HIV integrase inhibitors
AU8038798A (en) Cis-substituted fluoromethylpyrrolidine derivatives
AU6271098A (en) Hiv integrase inhibitors
AU8232498A (en) Gripping aid
AU3146997A (en) Pediatric formulation for hiv protease inhibitors
GB9815925D0 (en) HIV Intergrase inhibitors
AU3714800A (en) Hiv therapy
AU7689798A (en) Vif-derived hiv protease inhibitors
AU5274099A (en) Hiv vaccine
GB9707492D0 (en) HIV integrase inhibitors
AU9335998A (en) Bagatelle table
AU6984998A (en) Implement
GB9625326D0 (en) HIV integrase inhibitors